PALO ALTO, Calif.–Science Exchange, the world’s leading marketplace for outsourced R&D™, announced a collaboration with Pharmacelera to offer online access to its noteworthy computational chemistry services to researchers around the globe.
Pharmacelera is a Barcelona, Spain-based Computer-Aided Drug Design company whose mission is to develop disruptive in silico solutions to increase the productivity of biopharma research. Pharmacelera’s proprietary platform technology enables finding candidate molecules with higher accuracy and chemical diversity, significantly increasing the probability of success for drug discovery projects.
“We are delighted to work in association with Science Exchange to make our computational chemistry services more visible and accessible to scientists worldwide,” says Enric Gibert, CEO and co-founder of Pharmacelera. “Our proprietary technology enables researchers to increase the chemical diversity of their candidate molecules and helps amplify the efficiency of hit-to-lead optimization processes.”
“We are thrilled to team up with Pharmacelera to make its innovative computational chemistry technology available to our global life science research community,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “We are continuously adding new qualified and innovative providers to our network, giving scientists quick access to a comprehensive selection of research services. Pharmacelera has impressed us with their excellent progress in computational chemistry.”
Computational Chemistry Webinar May 30
Science Exchange and Pharmacelera will present a webinar with live Q&A on May 30 at 12 pm EST on the latest advances in virtual screening tools and how they can help chemists increase the chemical diversity of their leads. Medicinal chemists, computational chemists, and any others interested in small molecule drug design and development are encouraged to register at https://bit.ly/2IjnVJS.
Pharmacelera is a Computer-Aided Drug Design company developing disruptive computational chemistry solutions to find candidate molecules with more considerable chemical diversity. Pharmacelera’s solutions are based on more than 20 years of research in academia and use accurate 3D molecular descriptors that combine hydrophobic, electrostatic and steric interaction fields derived from semi-empirical quantum-mechanical (QM) computations. This allows screening libraries containing millions of compounds and finds new diverse chemical structures which show similar physicochemical properties to known leads. Such diversity is especially valuable when finding new intellectual property, generating backup compounds, translating natural product into a proper small molecule or overcoming pharmacological limitations of the molecular candidates. For more information, visit the Pharmacelera storefront or follow Pharmacelera on Twitter @pharmacelera and Linkedin.